Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

OCUL

Ocular Therapeutix Inc

May 08 • 04:00PM ET

9.65

-0.03 -0.31 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: EYPT RGNX KOD OCGN OPK

| Held by: VTI IWM VXF IWO PJP SCHA VTWO XPH DFAS IHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	9.58%	Shs Outstand	218.90M	Perf Week	2.33%
Market Cap	2.11B	Forward P/E	-	EPS next Y	-1.45	Insider Trans	-0.78%	Shs Float	197.99M	Perf Month	3.76%
Enterprise Value	1.53B	PEG	-	EPS next Q	-0.38	Inst Own	83.70%	Short Float	12.39%	Perf Quarter	5.35%
Income	-290.50M	P/S	40.60	EPS this Y	-9.45%	Inst Trans	4.11%	Short Ratio	4.59	Perf Half Y	-10.73%
Sales	52.04M	P/B	3.63	EPS next Y	6.92%	ROA	-51.03%	Short Interest	24.53M	Perf YTD	-20.51%
Book/sh	2.66	P/C	3.17	EPS next 5Y	4.75%	ROE	-68.55%	52W High	16.44 -41.30%	Perf Year	29.53%
Cash/sh	3.04	P/FCF	-	EPS past 3/5Y	-15.40% 11.13%	ROIC	-44.16%	52W Low	6.23 54.89%	Perf 3Y	50.78%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	0.29% 24.45%	Gross Margin	87.24%	Volatility	5.19% 4.91%	Perf 5Y	-40.62%
Dividend TTM	-	EV/Sales	29.32	EPS Y/Y TTM	-26.75%	Oper. Margin	-575.42%	ATR (14)	0.48	Perf 10Y	-5.02%
Dividend Ex-Date	-	Quick Ratio	14.73	Sales Y/Y TTM	-12.76%	Profit Margin	-558.24%	RSI (14)	57.03	Recom	1.08
Dividend Gr. 3/5Y	- -	Current Ratio	14.81	EPS Q/Q	-4.58%	SMA20	2.57%	Beta	0.92	Target Price	26.17
Payout	-	Debt/Eq	0.14	Sales Q/Q	0.81%	SMA50	5.94%	Rel Volume	0.39	Prev Close	9.68
Employees	325	LT Debt/Eq	0.13	Earnings	May 05 BMO	SMA200	-12.27%	Avg Volume	5.35M	Price	9.65
IPO	Jul 25, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-27.06% -15.23%	Trades		Volume	2,085,792	Change	-0.31%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)